Lotte Chemical Titan Tbk PT
IDX:FPNI
Lotte Chemical Titan Tbk PT
IDX:FPNI
Price:
190
IDR
Market Closed
Market Cap:
1.1T
IDR
Balance Sheet
Balance Sheet Decomposition
Lotte Chemical Titan Tbk PT
Lotte Chemical Titan Tbk PT
| Current Assets | 77.4m |
| Cash & Short-Term Investments | 15.2m |
| Receivables | 10.3m |
| Other Current Assets | 51.9m |
| Non-Current Assets | 86.2m |
| Long-Term Investments | 9.4m |
| PP&E | 56.9m |
| Intangibles | 63k |
| Other Non-Current Assets | 19.8m |
Balance Sheet
Lotte Chemical Titan Tbk PT
Lotte Chemical Titan Tbk PT
Currency: USD
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
4
|
3
|
3
|
3
|
5
|
6
|
7
|
3
|
2
|
|
| Cash |
2
|
4
|
3
|
3
|
3
|
5
|
6
|
7
|
3
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
32
|
33
|
23
|
13
|
|
| Total Receivables |
32
|
28
|
23
|
24
|
14
|
13
|
19
|
15
|
15
|
8
|
|
| Accounts Receivables |
30
|
28
|
22
|
22
|
12
|
13
|
16
|
14
|
13
|
8
|
|
| Other Receivables |
3
|
0
|
1
|
2
|
3
|
0
|
2
|
1
|
2
|
0
|
|
| Inventory |
58
|
52
|
50
|
59
|
45
|
45
|
55
|
60
|
50
|
47
|
|
| Other Current Assets |
12
|
3
|
11
|
7
|
9
|
9
|
6
|
4
|
4
|
5
|
|
| Total Current Assets |
105
|
88
|
88
|
92
|
71
|
72
|
117
|
119
|
95
|
75
|
|
| PP&E Net |
118
|
106
|
96
|
85
|
69
|
61
|
53
|
51
|
59
|
58
|
|
| PP&E Gross |
0
|
0
|
96
|
85
|
69
|
61
|
53
|
51
|
59
|
58
|
|
| Accumulated Depreciation |
0
|
0
|
319
|
332
|
345
|
357
|
368
|
373
|
379
|
385
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
8
|
8
|
8
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
2
|
2
|
0
|
10
|
9
|
8
|
4
|
11
|
19
|
17
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
8
|
8
|
8
|
10
|
10
|
9
|
|
| Other Long-Term Assets |
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Assets |
8
|
8
|
8
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
233
N/A
|
205
-12%
|
192
-6%
|
196
+2%
|
166
-15%
|
149
-10%
|
183
+23%
|
192
+5%
|
183
-5%
|
162
-11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
98
|
58
|
50
|
58
|
37
|
38
|
53
|
72
|
62
|
53
|
|
| Accrued Liabilities |
5
|
12
|
12
|
7
|
3
|
4
|
6
|
4
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
16
|
17
|
17
|
15
|
14
|
3
|
12
|
3
|
4
|
2
|
|
| Total Current Liabilities |
119
|
87
|
78
|
79
|
54
|
45
|
71
|
79
|
70
|
58
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
16
|
16
|
13
|
10
|
7
|
4
|
2
|
2
|
1
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
3
|
4
|
4
|
5
|
5
|
5
|
4
|
5
|
5
|
|
| Total Liabilities |
137
N/A
|
107
-22%
|
96
-10%
|
93
-3%
|
67
-29%
|
54
-18%
|
79
+45%
|
85
+8%
|
76
-11%
|
63
-16%
|
|
| Equity | |||||||||||
| Common Stock |
164
|
164
|
164
|
164
|
164
|
164
|
164
|
164
|
164
|
164
|
|
| Retained Earnings |
114
|
112
|
114
|
107
|
111
|
115
|
105
|
102
|
103
|
111
|
|
| Additional Paid In Capital |
46
|
46
|
46
|
46
|
46
|
46
|
46
|
46
|
46
|
46
|
|
| Total Equity |
96
N/A
|
98
+2%
|
96
-2%
|
103
+7%
|
99
-3%
|
95
-4%
|
104
+10%
|
107
+3%
|
107
0%
|
98
-8%
|
|
| Total Liabilities & Equity |
233
N/A
|
205
-12%
|
192
-6%
|
196
+2%
|
166
-15%
|
149
-10%
|
183
+23%
|
192
+5%
|
183
-5%
|
162
-11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5 566
|
5 566
|
5 566
|
5 566
|
5 566
|
5 566
|
5 566
|
5 566
|
5 566
|
5 566
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
